Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Gaudet

Showing results (141-150 of 304) with videos related to

Pageof 31
Sort By:
Journal of Clinical Lipidology|August 21, 2025
Brief communication: Strong concordance of the North American Familial Chylomicronemia Syndrome Score with a positive genetic diagnosis in patients from the Balance studyAlan S Brown, Philippe Moulin, Andrew Dibble, et al.
Journal of Lipid Research|November 18, 2004
Impact of adiponectin gene polymorphisms on plasma lipoprotein and adiponectin concentrations of viscerally obese menMarie-Thérèse Berthier, Alain Houde, Mélanie Côté, et al.
Epigenomics|March 4, 2014
ADRB3 gene promoter DNA methylation in blood and visceral adipose tissue is associated with metabolic disturbances in menSimon-Pierre Guay, Diane Brisson, Benoit Lamarche, et al.
Epigenomics|May 10, 2014
Epigenetic dysregulation of the IGF system in placenta of newborns exposed to maternal impaired glucose toleranceVéronique Desgagné, Marie-France Hivert, Julie St-Pierre, et al.
JAMA Psychiatry|September 5, 2012
Prenatal exposure to maternal cigarette smoking, amygdala volume, and fat intake in adolescenceAmirreza Haghighi, Deborah H Schwartz, Michal Abrahamowicz, et al.
Journal of Medical Genetics|April 29, 2021
Genetic burden linked to founder effects in Saguenay-Lac-Saint-Jean illustrates the importance of genetic screening test availabilityMbarka Bchetnia, Luigi Bouchard, Jean Mathieu, et al.
Journal of Clinical Lipidology|October 16, 2018
Efficacy, safety, and tolerability of evolocumab in pediatric patients with heterozygous familial hypercholesterolemia: Rationale and design of the HAUSER-RCT studyDaniel Gaudet, Gisle Langslet, Samuel S Gidding, et al.
Journal of Lipid Research|March 18, 2004
Relationship between cholesteryl ester transfer protein and LDL heterogeneity in familial hypercholesterolemiaJean-Charles Hogue, Benoît Lamarche, Daniel Gaudet, et al.
The Journal of Clinical Endocrinology and Metabolism|March 23, 2012
Effect of alipogene tiparvovec (AAV1-LPL(S447X)) on postprandial chylomicron metabolism in lipoprotein lipase-deficient patientsAndré C Carpentier, Frédérique Frisch, Sébastien M Labbé, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 22, 2006
Identification of a novel C5L2 variant (S323I) in a French Canadian family with familial combined hyperlipemiaMichel Marcil, Hai Vu, Wei Cui, et al.
Pageof 31

Showing results (141-150 of 304) with videos related to

Sort By:
Pageof 31
Journal of Clinical Lipidology|August 21, 2025
Brief communication: Strong concordance of the North American Familial Chylomicronemia Syndrome Score with a positive genetic diagnosis in patients from the Balance studyAlan S Brown, Philippe Moulin, Andrew Dibble, et al.
Journal of Lipid Research|November 18, 2004
Impact of adiponectin gene polymorphisms on plasma lipoprotein and adiponectin concentrations of viscerally obese menMarie-Thérèse Berthier, Alain Houde, Mélanie Côté, et al.
Epigenomics|March 4, 2014
ADRB3 gene promoter DNA methylation in blood and visceral adipose tissue is associated with metabolic disturbances in menSimon-Pierre Guay, Diane Brisson, Benoit Lamarche, et al.
Epigenomics|May 10, 2014
Epigenetic dysregulation of the IGF system in placenta of newborns exposed to maternal impaired glucose toleranceVéronique Desgagné, Marie-France Hivert, Julie St-Pierre, et al.
JAMA Psychiatry|September 5, 2012
Prenatal exposure to maternal cigarette smoking, amygdala volume, and fat intake in adolescenceAmirreza Haghighi, Deborah H Schwartz, Michal Abrahamowicz, et al.
Journal of Medical Genetics|April 29, 2021
Genetic burden linked to founder effects in Saguenay-Lac-Saint-Jean illustrates the importance of genetic screening test availabilityMbarka Bchetnia, Luigi Bouchard, Jean Mathieu, et al.
Journal of Clinical Lipidology|October 16, 2018
Efficacy, safety, and tolerability of evolocumab in pediatric patients with heterozygous familial hypercholesterolemia: Rationale and design of the HAUSER-RCT studyDaniel Gaudet, Gisle Langslet, Samuel S Gidding, et al.
Journal of Lipid Research|March 18, 2004
Relationship between cholesteryl ester transfer protein and LDL heterogeneity in familial hypercholesterolemiaJean-Charles Hogue, Benoît Lamarche, Daniel Gaudet, et al.
The Journal of Clinical Endocrinology and Metabolism|March 23, 2012
Effect of alipogene tiparvovec (AAV1-LPL(S447X)) on postprandial chylomicron metabolism in lipoprotein lipase-deficient patientsAndré C Carpentier, Frédérique Frisch, Sébastien M Labbé, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 22, 2006
Identification of a novel C5L2 variant (S323I) in a French Canadian family with familial combined hyperlipemiaMichel Marcil, Hai Vu, Wei Cui, et al.
Pageof 31